Aethlon Medical (AEMD) Depreciation & Amortization (CF) (2010 - 2026)
Aethlon Medical's (AEMD) quarterly Depreciation & Amortization (CF) came in at $79547.0 in Q1 2026, down 5.15% YoY from $83864.0 in Q1 2025, and down 2.52% on a QoQ basis from $81603.0 in Q4 2025.
Aethlon Medical (AEMD) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Aethlon Medical (AEMD) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $79547.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 5.15% year-over-year to $79547.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $323653.0 (down 4.68% YoY) and the FY2026 annual result came in at $323653.0, down 4.68% from the prior year.
- Depreciation & Amortization (CF) declined to $79547.0 in Q1 2026, from $81603.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $91473.0 in Q4 2023 to a low of $25322.0 in Q1 2022.
- A 5-year average of $75793.1 and a median of $82637.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- The widest YoY moves for Depreciation & Amortization (CF): up 342.06% in 2022, down 23.83% in 2022.
- Tracing AEMD's Depreciation & Amortization (CF) over 5 years: stood at $78126.0 in 2022, then grew by 17.08% to $91473.0 in 2023, then decreased by 8.38% to $83808.0 in 2024, then slipped by 2.63% to $81603.0 in 2025, then fell by 2.52% to $79547.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $79547.0 (Q1 2026), $81603.0 (Q4 2025), and $79866.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Aethlon Medical | 1.04 Mn | 1.04 Mn | - | 72,860.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 72,860.00 |
| Jun 30, 2026 | 72,860.00 |
| Mar 31, 2026 | 79,547.00 |
| Mar 31, 2026 | 79,547.00 |
| Dec 31, 2025 | 81,603.00 |
| Dec 31, 2025 | 81,603.00 |
| Sep 30, 2025 | 79,866.00 |
| Sep 30, 2025 | 79,866.00 |
| Jun 30, 2025 | 82,637.00 |
| Jun 30, 2025 | 82,637.00 |
| Mar 31, 2025 | 83,864.00 |
| Mar 31, 2025 | 83,864.00 |
| Dec 31, 2024 | 83,808.00 |
| Dec 31, 2024 | 83,808.00 |
| Sep 30, 2024 | 85,827.00 |
| Sep 30, 2024 | 85,827.00 |
| Jun 30, 2024 | 86,060.00 |
| Jun 30, 2024 | 86,060.00 |
| Mar 31, 2024 | 85,832.00 |
| Mar 31, 2024 | 85,832.00 |